Our Leadership Team

Executive Director

Executive Committee

Chair

Curt Oltmans
Fulcrum Therapeutic

Vice Chair

Del Lebel
Alexion, AstraZeneca Rare Disease

Secretary

Kathy Perez
argenx

Treasurer

Christopher Porter
Travere Therapeutics

Member-at-Large, Clinical / Pre-Clinical

Max Bronstein
Crinetics Pharmaceuticals

Member-at-Large, Commercial

Dianne Berry
Sarepta Therapeutics

Committee Chairs

Communications Committee Co-Chair

Molly Cameron
Marinus Pharmaceuticals

Federal Policy Committee Co-Chair

Lisa Kahlman
Ultragenyx

Federal Policy Committee Co-Chair

Stephanie Kelly
Kyowa Kirin